ALX ONCOLOGY HOLDINGS INC Contractual Obligation, to be Paid, Year One
ALX ONCOLOGY HOLDINGS INC (ALXO) had Contractual Obligation, to be Paid, Year One of $860.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity
us-gaap:ContractualObligationDueInNextTwelveMonths · last filed 2026-03-09
- 2025-12-31: Contractual Obligation, to be Paid, Year One $860.00K.
- 2024-12-31: Contractual Obligation, to be Paid, Year One $1.99M.
- 2023-12-31: Contractual Obligation, to be Paid, Year One $6.54M.
- 2023-03-31: Contractual Obligation, to be Paid, Year One $12.30M.
| Period end | Contractual Obligation, to be Paid, Year One |
|---|---|
| 2025-12-31 | $860.00K 10-K · filed 2026-03-09 |
| 2024-12-31 | $1.99M 10-K · filed 2025-03-06 |
| 2023-12-31 | $6.54M 10-K · filed 2024-03-07 |
| 2023-03-31 | $12.30M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $9.59M 10-K · filed 2023-03-09 |
| 2021-12-31 | $18.53M 10-K · filed 2022-02-28 |
| 2020-12-31 | $6.43M 10-K · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |